23 May 2013
Keywords: topo, inhibitors, show, potential, sclc, small-cell, lung
Article | 06 November 1995
Small-cell lung cancer is a disease which follows an extremely
aggressive course but, paradoxically, is much more responsive to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 November 1995
22 May 2013
© 2013 thepharmaletter.com